Multiple Sclerosis with Negative Spinal Fluid: Diagnostic Nuances
A negative cerebrospinal fluid (CSF) analysis does not exclude multiple sclerosis (MS). Up to 5–10% of confirmed MS patients have normal CSF.
CSF Findings in MS
- Oligoclonal Bands (OCBs): Present in 85–95% (isoelectric focusing + IgG index). Gold standard.
- Elevated IgG Index: > 0.7 suggests intrathecal synthesis.
- Pleocytosis: Mild lymphocytic elevation (< 50 cells/µL) in acute attacks.
Reasons for False-Negative CSF
- Early Disease: OCBs may appear months after first attack.
- Technical Factors: Insufficient volume, improper handling, insensitive assay.
- Atypical Phenotypes: Primary progressive MS has lower OCB positivity (~70–80%).
- Concurrent Immunosuppression: Steroids, rituximab can suppress bands.
Diagnostic Framework (McDonald Criteria 2017)
MS diagnosis requires dissemination in space (DIS) + dissemination in time (DIT) + exclusion of mimics. CSF OCBs can substitute for DIT. If CSF negative, rely on:
- MRI: DIS (lesions in ≥2 of 4 CNS regions) + DIT (simultaneous gad+/gad- lesions or new lesion on follow-up).
- Clinical: Multiple attacks + objective evidence of ≥2 lesions.
- VEP/OCT: Supportive for optic nerve involvement.
Clinical Action
If MS suspected despite negative CSF: repeat LP in 3–6 months, advanced MRI (3T, double inversion recovery), serum MOG-AQP4 antibodies (exclude NMOSD), neuropsychological testing. Refer to MS specialist.
Multiple Sclerosis - Related Articles
- Multiple Sclerosis (MS): Early Symptoms to Recognize
- Cranial Electrotherapy Stimulation (CES) for Multiple Sclerosis: A Review
- Multiple Sclerosis (MS): Symptoms, Causes & Management
- Scleroderma: Causes, Risk Factors, and Pathophysiology
- Embryonic Stem Cell Treatment for Multiple Sclerosis: Cost & Potential
- Foot Drop Exercises for Multiple Sclerosis: Improve Mobility & Strength
- Managing Multiple Sclerosis Spasticity: Strategies & Treatments
